William Beaumont Hospital-Ophthalmology Research

Royal Oak, Michigan 48073

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Macular Degeneration Clinical Trial
Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling, Phase I, II
Updated: 1/7/2016
mi
from
Royal Oak, MI
Click here to add this to my saved trials